Physician Wealth Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$274K Sell
1,997
-73
-4% -$10.3K 0.03% 171
2026
Q2
$303K Buy
2,070
+128
+7% +$23.2K 0.04% 158
2026
Q1
$286K Buy
1,942
+682
+54% +$111K 0.04% 155
2025
Q4
$246K Sell
1,260
-438
-26% -$104K 0.03% 167
2025
Q3
$478K Sell
1,698
-128
-7% -$32.6K 0.07% 111
2025
Q2
$399K Sell
1,826
-27
-1% -$4.36K 0.06% 118
2025
Q1
$259K Sell
1,853
-93
-5% -$15.1K 0.04% 150
2024
Q4
$324K Buy
1,946
+283
+17% +$50.3K 0.05% 131
2024
Q3
$290K Hold
1,663
– – 0.05% 137
2024
Q2
$237K Hold
1,663
– – 0.04% 155
2024
Q1
$201K Buy
+1,663
New +$190K 0.04% 172

Other funds holding ORCL

Physician Wealth Advisors's ORCL Position: Q3 2026 in Review

Physician Wealth Advisors reduced its Oracle (ORCL) stake by 3.5% in Q3 2026, selling an estimated $10.3K and leaving 1,997 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #171.

Physician Wealth Advisors first reported a position in ORCL in Q1 2024 and has held it in 11 quarters since. The position peaked at $478K in Q3 2025. 2,069 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Physician Wealth Advisors held 1,997 shares of Oracle worth $274K as of Q3 2026.
  • Physician Wealth Advisors sold 73 Oracle shares in Q3 2026, an estimated $10.3K.
  • Oracle made up 0.03% of Physician Wealth Advisors's portfolio in Q3 2026, its #171 holding.
  • Physician Wealth Advisors first reported a position in Oracle in Q1 2024 and has held it in 11 quarters since.
  • Physician Wealth Advisors's Oracle position peaked at $478K in Q3 2025.
  • 2,069 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.